Harmony Biosciences (HRMY) Stock Forecast & Price Target

HRMY$33.76-0.04 -0.12%
BiotechnologyValue StockGrowth StockHigh Quality
Compare
Market cap$1.98BEnterprise value$1.38BRevenue (TTM)$989.36MMarket position—

Score

74
Bullish
Value
70
Quality
77
Growth
76

Harmony Biosciences Holdings, Inc. price target

HRMY
Low$34.00
Average$48.67
High$70.00
Upside vs current price+44.2%

The average target of $48.67 is +44.2% versus the current HRMY price of $33.76.

Harmony Biosciences Holdings, Inc. analyst ratings

RatingAnalysts
Strong buy2
Buy6
Hold3
Sell0
Strong sell1
ConsensusBuy

12 analysts cover HRMY.

Harmony Biosciences Holdings, Inc. EPS and revenue estimates

Published annual figures for HRMY on this page are 2026 EPS $3.91, 2027 EPS $4.45. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$3.91$1.03B
2027$4.45$1.17B

Is Harmony Biosciences Holdings, Inc. a buy or sell?

Of the 12 analysts covering Harmony Biosciences Holdings, Inc., 8 rate it a buy (2 strong buy and 6 buy), 3 rate it a hold, and 1 rates it a sell (0 sell and 1 strong sell).

The HRMY consensus label is Buy, beside 8 buy-side ratings and 1 sell-side ratings.

The average target of $48.67 implies +44.2% versus the current price of $33.76.

The HRMY rating block is 12 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the Harmony Biosciences Holdings, Inc. forecast

A wide spread is the story on HRMY. Targets run from $34.00 to $70.00, with $48.67 as the average.

The gap from the $33.76 price to the HRMY average is +44.2%.

The HRMY rating mix is lopsided rather than split: 8 of 12 analysts are on the buy side, 3 are at hold, and 1 is on the sell side, and the published consensus is Buy.

Month by month, the HRMY average target is higher ($49.00) than the quarterly average ($43.50).

With 12 analysts on HRMY, the average is a small sample.

Harmony Biosciences Holdings, Inc. forecast questions

What is the HRMY price target?

The published range for HRMY is $34.00 to $70.00, with an average of $48.67. That average is +44.2% versus the current price of $33.76.

Is Harmony Biosciences Holdings, Inc. a buy or sell?

Of the 12 analysts covering Harmony Biosciences Holdings, Inc., 8 rate it a buy, 3 rate it a hold, and 1 rates it a sell. The consensus is Buy, leaving HRMY at 8 buy ratings, 3 holds, and 1 sells.

What is the EPS estimate for Harmony Biosciences Holdings, Inc.?

Analyst EPS estimates for Harmony Biosciences Holdings, Inc.: 2026 $3.91, 2027 $4.45.

What is the revenue estimate for Harmony Biosciences Holdings, Inc.?

Analyst revenue estimates for Harmony Biosciences Holdings, Inc.: 2026 $1.03B, 2027 $1.17B.

How many analysts cover HRMY?

12 analysts cover HRMY. Their consensus on HRMY is Buy, across those 12.

HRMY price $33.76 -0.04 -0.12%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener